Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10,781,082
-
Total 13F shares
-
1,658,393
-
Share change
-
+207,764
-
Total reported value
-
$13,121,000
-
Price per share
-
$7.98
-
Number of holders
-
31
-
Value change
-
-$563,118
-
Number of buys
-
23
-
Number of sells
-
7
Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q4 2021
As of 31 Dec 2021,
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,658,393 shares.
The largest 10 holders included
VANGUARD GROUP INC, SANDERS MORRIS HARRIS LLC, NewEdge Advisors, LLC, CARLSON CAPITAL L P, TWO SIGMA INVESTMENTS, LP, Anson Funds Management LP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Lynwood Capital Management Inc., and Redmond Asset Management, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.